An observational study in Polycystic Ovary Syndrome, Endometriosis and Hyperprolactinemia, sponsored by University of Zurich. Completed at 1 site in Switzerland. Open to female participants aged 18 Months to 43 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-09-07.
Sponsored by University of Zurich · Observational
Development of a bio-mathematical model of the human female cycle
From hormonal measurements throughout 1-2 menstrual cycles in women with and without endocrinological pathology a mathematical model of the human menstrual cycle will be generated. The model will serve to predict development of the cycle including ovulation as well as to better understand the pathophysiology of endocrinological disorder. In a second step current treatment protocols for fertility treatment will be integrated into the model in order to optimize treatment outcome.
956 studies on the registry are indexed under Polycystic Ovary Syndrome; 176 are open to participants now.
This study's enrollment of 123 is close to the median of 118 across 223 observational studies indexed under Polycystic Ovary Syndrome.
Browse Polycystic Ovary Syndrome studies →University of Zurich is the lead sponsor of 1,049 studies on the registry; 133 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women with normal and distrubed menstrual cycles Women receiving fertility treatment
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
healthy women PCOS Endometriosis hyperprolactinemia fertility treatment
Other: Fertility treatment
Fertility treatment
Hormonal parameters
Development of a mathematical model of the menstrual cycle
Time frame: 3 years
Dynamics of fertility treatment
Mathematical model to improve fertility treatments
Time frame: 2 years
Dynamics of gyneco-endocrinological diseases
To better understand the pathophysiological mechanisms in endocrinological diseases
Time frame: 3 years
Plan to share: Undecided
This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.